Schizoaffective Disorder News and Research

RSS

Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces completion of patient enrollment in the phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.

16 Jan 2013

Metabolic syndrome linked to poorer cognition in schizophrenia

Schizophrenia patients with the metabolic syndrome have poorer cognitive functioning than those without, results from a US study show.

9 Nov 2012

People in creative professions are treated more often for mental illness

People in creative professions are treated more often for mental illness than the general population, there being a particularly salient connection between writing and schizophrenia. This according to researchers at Karolinska Institutet in Sweden, whose large-scale registry study is the most comprehensive ever in its field.

17 Oct 2012

Maternal obstetric problems linked to schizophrenia risk

Certain maternal pregnancy complications are associated with an increased risk for schizophrenia spectrum psychoses among individuals at high genetic risk for the condition, Finnish research shows.

25 Sep 2012

Kynurenic acid levels reduced in suicide attempters with schizophrenia

Cerebrospinal fluid concentrations of kynurenic acid are significantly lower in schizophrenia-spectrum patients with a history of suicide attempts than in those without, researchers report.

13 Sep 2012

Night eating syndrome increased in schizophrenia patients

The prevalence of night eating syndrome is significantly increased among patients with schizophrenia or schizoaffective disorder who are obese, results from a US study suggest.

6 Sep 2012

DUP may differentiate schizoaffective disorder from BD

Among individuals with a first episode of psychotic mania (FEPM), a longer duration of untreated psychosis may differentiate patients with schizoaffective disorder from those with bipolar I disorder, study results suggest.

29 Aug 2012

Interhemispheric coordination reduced in schizophrenia

Results from a US study show that patients with schizophrenia have significantly decreased interhemispheric coordination compared with mentally healthy individuals.

21 Aug 2012

PTSD prevalent in serious mental illness patients

Post-traumatic stress disorder is common among patients with serious mental illnesses, and is associated with an increased risk for suicide attempts, Spanish researchers report.

2 Aug 2012

SCIT may benefit affective disorder patients

Social cognition and interaction training may improve certain aspects of social cognition and functioning in patients with affective disorders, results from a preliminary study suggest.

27 Jul 2012

PTSD prevalent in serious mental illness patients

Post-traumatic stress disorder is common among patients with serious mental illnesses, and is associated with an increased risk for suicide attempts, Spanish researchers report.

26 Jul 2012

Cognitive function linked to suicidality in schizophrenia

Patients with schizophrenia who have contemplated suicide or made one suicide attempt have better cognitive functioning than those who have not, research shows.

19 Jul 2012

Obsessive compulsive symptoms impair life quality in psychosis patients

The presence of obsessive compulsive symptoms is associated with reduced subjective wellbeing and quality of life in patients with a first episode of psychosis, Dutch researchers report.

17 Jul 2012

Cannabis use may reduce mortality risk in psychosis patients

Cannabis use is associated with reduced mortality risk in patients with psychotic disorders, study results suggest.

10 Jul 2012

Psychiatric inpatients have low vitamin D levels

Results from a New Zealand study show that vitamin D deficiency is common in psychiatric inpatients, particularly among patients with schizophrenia and those of Maori descent.

27 Jun 2012

MAGI genes play a role in psychiatric disease

These findings are not about the classic story of gift-giving, although the MAGI genes (officially named membrane associated guanylate kinase, WW and PDZ domain containing proteins) do influence brain function in important ways.

11 May 2012

Study evaluates efficacy of CBT in obsessive-compulsive disorder

This study evaluates the efficacy of a specialized form of psychotherapy (cognitive behavioral therapy) in clinical presentations characterized by the joint presence of obsessions and psychotic symptoms.

30 Mar 2012

Smartphone technology can help assess and treat schizophrenia

Psychiatry is employing smartphone technology as an innovative tool in the assessment and treatment of schizophrenia and other serious mental illness. Prominent in this endeavor is Dror Ben-Zeev, an assistant professor of psychiatry at Dartmouth Medical School and director of the Thresholds-Dartmouth Research Center in Chicago.

16 Mar 2012

Reviva to initiate enrollment in RP503 phase 2 study for schizophrenia

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of patients in its phase 2 clinical study of RP503 for schizophrenia and schizoaffective disorder.

13 Mar 2012

Viewpoints: Paul Starr on Obama, Romney and health reform; Glenn close on the need for mental health services

As we testified on Nov. 1 before the Joint Select Committee on Deficit Reduction, the principal driver of long-term federal deficits is the rapidly mounting cost of healthcare, particularly Medicare. ... Solving the U.S. debt crisis requires structural changes to slow Medicare's cost growth plus significant new revenue to accommodate the retirement of the baby boomers. Any plan without those two essential components should go back to the drawing board.

17 Nov 2011